Stanley R Riddell (Stanley Riddell)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Topics

High Throughput Sequencing

Top Venues

Science immunology

Science signaling

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Simone A Minnie, Olivia G Waltner, Ping Zhang, Shuichiro Takahashi, Nicole S Nemychenkov, Kathleen S Ensbey, Christine R Schmidt, Samuel R W Legg, Melissa Comstock, Julie R Boiko, Ethan Nelson, Shruti S Bhise, Alec B Wilkens, Motoko Koyama, Madhav V Dhodapkar, Marta Chesi, Stanley R Riddell, Damian J Green, Andrew Spencer, Scott N Furlan, Geoffrey R Hill
TIM-3 + CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies. Science immunology 9 (94) (2024)
Simone A Minnie, Olivia G Waltner, Ping Zhang, Shuichiro Takahashi, Nicole S Nemychenkov, Kathleen S Ensbey, Christine R Schmidt, Samuel R W Legg, Melissa Comstock, Julie R Boiko, Ethan Nelson, Shruti S Bhise, Alec B Wilkens, Motoko Koyama, Madhav V Dhodapkar, Marta Chesi, Stanley R Riddell, Damian J Green, Andrew Spencer, Scott N Furlan, Geoffrey R Hill
TIM-3 + CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies. Science immunology 9 (94) (2024)
Simone A Minnie, Olivia G Waltner, Ping Zhang, Shuichiro Takahashi, Nicole S Nemychenkov, Kathleen S Ensbey, Christine R Schmidt, Samuel R W Legg, Melissa Comstock, Julie R Boiko, Ethan Nelson, Shruti S Bhise, Alec B Wilkens, Motoko Koyama, Madhav V Dhodapkar, Marta Chesi, Stanley R Riddell, Damian J Green, Andrew Spencer, Scott N Furlan, Geoffrey R Hill
TIM-3 + CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies. Science immunology 9 (94) (2024)
Simone A Minnie, Olivia G Waltner, Ping Zhang, Shuichiro Takahashi, Nicole S Nemychenkov, Kathleen S Ensbey, Christine R Schmidt, Samuel R W Legg, Melissa Comstock, Julie R Boiko, Ethan Nelson, Shruti S Bhise, Alec B Wilkens, Motoko Koyama, Madhav V Dhodapkar, Marta Chesi, Stanley R Riddell, Damian J Green, Andrew Spencer, Scott N Furlan, Geoffrey R Hill
TIM-3 + CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies. Science immunology 9 (94) (2024)
Simone A Minnie, Olivia G Waltner, Ping Zhang, Shuichiro Takahashi, Nicole S Nemychenkov, Kathleen S Ensbey, Christine R Schmidt, Samuel R W Legg, Melissa Comstock, Julie R Boiko, Ethan Nelson, Shruti S Bhise, Alec B Wilkens, Motoko Koyama, Madhav V Dhodapkar, Marta Chesi, Stanley R Riddell, Damian J Green, Andrew Spencer, Scott N Furlan, Geoffrey R Hill
TIM-3 + CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies. Science immunology 9 (94) (2024)
Simone A Minnie, Olivia G Waltner, Ping Zhang, Shuichiro Takahashi, Nicole S Nemychenkov, Kathleen S Ensbey, Christine R Schmidt, Samuel R W Legg, Melissa Comstock, Julie R Boiko, Ethan Nelson, Shruti S Bhise, Alec B Wilkens, Motoko Koyama, Madhav V Dhodapkar, Marta Chesi, Stanley R Riddell, Damian J Green, Andrew Spencer, Scott N Furlan, Geoffrey R Hill
TIM-3 + CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies. Science immunology 9 (94) (2024)
Simone A Minnie, Olivia G Waltner, Ping Zhang, Shuichiro Takahashi, Nicole S Nemychenkov, Kathleen S Ensbey, Christine R Schmidt, Samuel R W Legg, Melissa Comstock, Julie R Boiko, Ethan Nelson, Shruti S Bhise, Alec B Wilkens, Motoko Koyama, Madhav V Dhodapkar, Marta Chesi, Stanley R Riddell, Damian J Green, Andrew Spencer, Scott N Furlan, Geoffrey R Hill
TIM-3 + CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies. Science immunology 9 (94) (2024)
Joshua R Veatch, Stanley R Riddell
Stem-cell-like CD4 + T cells prey on MHC class II-negative tumors. Nature immunology (2023)
Marie Bleakley, Alison Sehgal, Stuart Seropian, Melinda A Biernacki, Elizabeth F Krakow, Ann Dahlberg, Heather Persinger, Barbara Hilzinger, Paul J Martin, Paul A Carpenter, Mary Evelyn Flowers, Jenna Voutsinas, Theodore A Gooley, Keith R Loeb, Brent L Wood, Shelly Heimfeld, Stanley R Riddell, Warren D Shlomchik
Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (11) (2022)
Shihong Zhang, R Graeme Black, Karan Kohli, Brian J Hayes, Cassandra Miller, Amanda L Koehne, Brett A Schroeder, Kraig Abrams, Brian C Schulte, Borislav A Alexiev, Amy B Heimberger, Ali Zhang, Weiqing Jing, Juliana Chi Kei Ng, Himaly Shinglot, Bernard Séguin, Alexander I Salter, Stanley R Riddell, Michael C Jensen, Stephen Gottschalk, Peter F Moore, Beverly Torok-Storb, Seth M Pollack
B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model. Molecular cancer therapeutics 21 (6) (2022)
Vandana Kalia, Yevgeniy Yuzefpolskiy, Adithya Vegaraju, Hanxi Xiao, Florian Baumann, Shashank Jatav, Candice D Church, Martin Prlic, Abhishek Jha, Paul T Nghiem, Stanley R Riddell, Surojit Sarkar
Metabolic regulation by PD-1 signaling promotes long-lived quiescent CD8 T cell memory in mice. Science translational medicine 13 (615) (2021)
Alexander I Salter, Anusha Rajan, Jacob J Kennedy, Richard G Ivey, Sarah A Shelby, Isabel Leung, Megan L Templeton, Vishaka Muhunthan, Valentin Voillet, Daniel Sommermeyer, Jeffrey R Whiteaker, Raphaël Gottardo, Sarah L Veatch, Amanda G Paulovich, Stanley R Riddell
Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function. Science signaling 14 (697) (2021)
Marc J Lajoie, Scott E Boyken, Alexander I Salter, Jilliane Bruffey, Anusha Rajan, Robert A Langan, Audrey Olshefsky, Vishaka Muhunthan, Matthew J Bick, Mesfin M Gewe, Alfredo Quijano-Rubio, JayLee Johnson, Garreck H Lenz, Alisha Nguyen, Suzie H Pun, Colin E Correnti, Stanley R Riddell, Julien S Baker
Designed protein logic to target cells with precise combinations of surface antigens. Science (New York, N.Y.) 369 (6511) (2020)
Alexandre V Hirayama, Jordan Gauthier, Kevin Anthony Hay, Jenna M Voutsinas, Qian Wu, Ted Gooley, Daniel Li, Sindhu Cherian, Xueyan Chen, Barbara S Pender, Reed M Hawkins, Aesha Vakil, Rachel N Steinmetz, Utkarsh H Acharya, Ryan D Cassaday, Aude G Chapuis, Tejaswini M Dhawale, Paul C Hendrie, Hans-Peter Kiem, Ryan C Lynch, Jorge Ramos, Mazyar Shadman, Brian G Till, Stanley R Riddell, David G Maloney, Cameron J Turtle
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells. Blood 133 (17) (2019)
Kevin Anthony Hay, Jordan Gauthier, Alexandre V Hirayama, Jenna M Voutsinas, Qian Vicky Wu, Daniel Li, Theodore A Gooley, Sindhu Cherian, Xueyan Chen, Barbara S Pender, Reed M Hawkins, Aesha Vakil, Rachel N Steinmetz, Gary Schoch, Aude G Chapuis, Brian G Till, Hans-Peter Kiem, Jorge D Ramos, Mazyar Shadman, Ryan D Cassaday, Utkarsh H Acharya, Stanley R Riddell, David G Maloney, Cameron J Turtle
Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy. Blood 133 (15) (2019)
Alexander I Salter, Richard G Ivey, Jacob J Kennedy, Valentin Voillet, Anusha Rajan, Eva J Alderman, Uliana J Voytovich, Chenwei Lin, Daniel Sommermeyer, Lingfeng Liu, Jeffrey R Whiteaker, Raphaël Gottardo, Amanda G Paulovich, Stanley R Riddell
Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function. Science signaling 11 (544) (2018)
Alexander I Salter, Margot J Pont, Stanley R Riddell
Chimeric antigen receptor-modified T cells: CD19 and the road beyond. Blood 131 (24) (2018)
Kevin Anthony Hay, Laïla-Aïcha Hanafi, Daniel Li, Juliane Gust, W Conrad Liles, Mark M Wurfel, José A López, Junmei Chen, Dominic Chung, Susanna Harju-Baker, Sindhu Cherian, Xueyan Chen, Stanley R Riddell, David G Maloney, Cameron J Turtle
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy. Blood 130 (21) (2017)